Citigroup
ANGO icon

Citigroup’s AngioDynamics ANGO Stock Holding History

Citigroup’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.1K Buy
6,167
+5,278
+594% +$57.2K ﹤0.01% 4405
2025
Q4 		$11.4K Sell
889
-462
-34% -$5.7K ﹤0.01% 5017
2025
Q3 		$15.1K Sell
1,351
-12,707
-90% -$123K ﹤0.01% 4904
2025
Q2 		$139K Sell
14,058
-13,380
-49% -$131K ﹤0.01% 4251
2025
Q1 		$258K Sell
27,438
-2,947
-10% -$31K ﹤0.01% 4053
2024
Q4 		$278K Buy
30,385
+2,091
+7% +$15.4K ﹤0.01% 4195
2024
Q3 		$220K Buy
28,294
+19,221
+212% +$139K ﹤0.01% 4270
2024
Q2 		$54.9K Buy
9,073
+1,297
+17% +$8K ﹤0.01% 4522
2024
Q1 		$45.6K Buy
7,776
+2,174
+39% +$12.9K ﹤0.01% 4674
2023
Q4 		$43.9K Buy
5,602
+5,271
+1,592% +$36.6K ﹤0.01% 4594
2023
Q3 		$2.42K Sell
331
-32,249
-99% -$268K ﹤0.01% 4912
2023
Q2 		$340K Buy
32,580
+9,960
+44% +$95.9K ﹤0.01% 3613
2023
Q1 		$234K Sell
22,620
-4,865
-18% -$62.3K ﹤0.01% 3647
2022
Q4 		$378K Buy
27,485
+4,986
+22% +$69.4K ﹤0.01% 3352
2022
Q3 		$460K Buy
22,499
+1,352
+6% +$29.7K ﹤0.01% 3299
2022
Q2 		$409K Sell
21,147
-16,322
-44% -$334K ﹤0.01% 3382
2022
Q1 		$807K Buy
37,469
+439
+1% +$9.96K ﹤0.01% 3151
2021
Q4 		$1.02M Buy
37,030
+9,686
+35% +$267K ﹤0.01% 3232
2021
Q3 		$709K Sell
27,344
-6,702
-20% -$179K ﹤0.01% 3357
2021
Q2 		$924K Buy
34,046
+16,911
+99% +$413K ﹤0.01% 3292
2021
Q1 		$401K Buy
17,135
+7,456
+77% +$151K ﹤0.01% 3595
2020
Q4 		$148K Buy
9,679
+6,900
+248% +$87.6K ﹤0.01% 5219
2020
Q3 		$34K Sell
2,779
-14,561
-84% -$138K ﹤0.01% 5840
2020
Q2 		$176K Sell
17,340
-208
-1% -$2.14K ﹤0.01% 5114
2020
Q1 		$183K Sell
17,548
-39,803
-69% -$500K ﹤0.01% 4805
2019
Q4 		$919K Buy
57,351
+22,879
+66% +$349K ﹤0.01% 3835
2019
Q3 		$635K Sell
34,472
-464
-1% -$9.07K ﹤0.01% 4111
2019
Q2 		$688K Buy
34,936
+1,132
+3% +$23.1K ﹤0.01% 4089
2019
Q1 		$773K Buy
33,804
+282
+0.8% +$6.12K ﹤0.01% 3688
2018
Q4 		$675K Buy
33,522
+8,334
+33% +$172K ﹤0.01% 3807
2018
Q3 		$548K Buy
25,188
+10,804
+75% +$240K ﹤0.01% 4168
2018
Q2 		$320K Sell
14,384
-473
-3% -$9.67K ﹤0.01% 4563
2018
Q1 		$256K Sell
14,857
-3,131
-17% -$52.2K ﹤0.01% 4691
2017
Q4 		$299K Sell
17,988
-17,353
-49% -$296K ﹤0.01% 4646
2017
Q3 		$604K Sell
35,341
-39,095
-53% -$657K ﹤0.01% 3914
2017
Q2 		$1.21M Buy
74,436
+32,638
+78% +$516K ﹤0.01% 3115
2017
Q1 		$725K Sell
41,798
-20,002
-32% -$334K ﹤0.01% 3544
2016
Q4 		$1.04M Buy
61,800
+33,761
+120% +$563K ﹤0.01% 3649
2016
Q3 		$492K Buy
28,039
+12,406
+79% +$201K ﹤0.01% 3903
2016
Q2 		$224K Sell
15,633
-2,408
-13% -$30.1K ﹤0.01% 4384
2016
Q1 		$221K Buy
18,041
+17,674
+4,816% +$195K ﹤0.01% 4989
2015
Q4 		$4K Buy
367
+363
+9,075% +$4.47K ﹤0.01% 7094
2015
Q3 		$0 Sell
4
-423
-99% -$6.39K ﹤0.01% 7350
2015
Q2 		$7K Sell
427
-202
-32% -$3.35K ﹤0.01% 6610
2015
Q1 		$12K Sell
629
-25,566
-98% -$475K ﹤0.01% 6365
2014
Q4 		$498K Sell
26,195
-44,814
-63% -$759K ﹤0.01% 3891
2014
Q3 		$974K Buy
71,009
+70,443
+12,446% +$1.01M ﹤0.01% 3035
2014
Q2 		$9K Sell
566
-7,060
-93% -$102K ﹤0.01% 6204
2014
Q1 		$120K Sell
7,626
-1,566
-17% -$25.5K ﹤0.01% 4820
2013
Q4 		$158K Buy
9,192
+4,687
+104% +$72.1K ﹤0.01% 4868
2013
Q3 		$60K Sell
4,505
-6,215
-58% -$73.3K ﹤0.01% 5138
2013
Q2 		$121K Buy
+10,720
New +$114K ﹤0.01% 4693

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Citigroup's ANGO Position: Q1 2026 in Review

Citigroup increased its AngioDynamics (ANGO) stake by 594% in Q1 2026, buying an estimated $57.2K and bringing the position to 6,167 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4405.

Citigroup first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.21M in Q2 2017. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Citigroup held 6,167 shares of AngioDynamics worth $70.1K as of Q1 2026.
  • Citigroup bought 5,278 AngioDynamics shares in Q1 2026, an estimated $57.2K.
  • AngioDynamics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4405 holding.
  • Citigroup first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's AngioDynamics position peaked at $1.21M in Q2 2017.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.